The effects of intravenous pindolol on the electrophysiologic properties of the atrioventricular conduction system was studied in intact dog, using His bundle electrogram and the extrastimulus method.
The effects of intravenous pindolol on the electrophysiologic properties of the atrioventricular conduction system was studied in intact dog, using His bundle electrogram and the extrastimulus method.
Pindolol was administered intravenously in a dose range of 4 to 40 ttg/Kg. The latter dosage of pindolol is above those used clinically.
Significant effects of intravenous pindolol were observed on sinus cycle length, the A-V nodal conduction time, the ERP of the atrium, the ERP and FRP of the A-V node, and the ERP of the ventricle.
Sinus cycle length was prolonged during sinus rhythm. Intraatrial conduction time was not altered by pindolol, while the ERP of the atrium was slightly increased. The A-H interval was generally prolonged by pindolol without Wenckebach type A-V block, but the H-V interval was unchanged. Both ERP and FRP of the A-V node were prolonged.
The ERP and RRP of the His-Purkinje system were not statistically evaluated, because no block within the His-Purkinje system or prolongation of H-V interval was produced and only a few QRS complexes by extrastimulus showed aberrant configration in the intact canine heart. The purpose of the present study was to evaluate the effects of pindolol on the conduction times and the refractory periods of the atrioventricular conduction system of canine heart using His bundle electrogram and the extrastimulus method.
MATERIALS AND METHODS
In the present study, dogs weighing 8 to 20Kg were anesthetized with intravenous sodium pentobarbital (35mg/Kg). They were intubated, placed on artificial ventilation and supplied with 100% oxygen, without opening the chest throughout the experiment.
For the first experiment, 40dogs were used to evaluate the effects of pindolol on sinus cycle length and the conduction times of the atrioventricular conduction system. They were divided into 4groups of 10dogs each. A hexapolar catheter (ELECATH) was percutaneously introduced into the right femoral vein and positioned across the tricuspid valve to record the electrical activity from the bundle of His. The proximal terminals of the electrode catheter were plugged into a multichannel distribution switch box which permitted the selection of any 2 electrodes for bipolar recordings. Care was taken to insure adequate grounding of all equipments by data display on a multichannel oscilloscope of Fukuda Electro Co, Ltd, MCM-8000. A bipolar catheter was positioned at the high right atrium via the right jugular vein. The standard electrocardiogram (Lead II or Lead I, II, III) was simultaneously recorded on photographic paper at a speed of 250mm/sec by Sanei-sokki Co, Ltd, Model 100A. Time lines were generated at intervals of 10and 100msec. Pindolol was administered into the left femoral vein for 3min at doses of 4pg/Kg, 20pg/Kg, 40pg/Kg to groups 1, 2, and 3, respectively. Group 4 was used for control.
This first experiment was undertaken for 60min. Sinus cycle length, the P-A, A-H, H-V, and QRS intervals were measured according to Hecht and associates. 9) Secondly, studies on the refractory periods of the atrium, A-V node and HisPurkinje system were performed by the extrastimulus method. Another bipolar catheter was inserted into the high right atrium via the left jugular vein. The basic driving stimulus (S1) at a rate slightly faster than the underlying sinus rate and the extrastimulus (S2) were delivered from Electronic Stimulator 3F-3l (Saneisokki Co, Ltd). The extrastimulus was introduced after every 8beats, moving progressively earlier by 5msec decrements in successive test cycles. The refractory period of the ventricle was measured by the extrastimulus method under right ventricular pacing. In these studies on the refractory periods, intravenous pindolol was administered in doses of 4pg/Kg, 20pg/Kg, and 40pg/Kg, respectively, to other 10dogs each in the same way as in the first experiment. Then the same experiment was carried out.
In the third experiment, the effects of pindolol on the atrioventricular conduction times under atrial pacing, were evaluated by administration of 4beg/Kg and 40pg/Kg, respectively, to 2 groups of 10dogs each. The result under atrial pacing was compared with that without pacing in the first experiment.
Definition of the terms:
The P-A interval as measured from the onset of the P wave to the onset of the atrial electrogram, was taken as a measure of intraatrial conduction time .
The A-H interval as measured from the onset of the atrial electrogram to the first high frequency component of the His bundle electrogram, was taken as a measure of A-V nodal conduction time.
The H-V interval as measured from initial deflection of His potential to the earliest point of ventricular depolarization, was taken as a measure of His-Purkinje conduction time.
A1, H1, and V1 represent the atrial, His bundle, and ventricular electrograms of the basically driven beats.
A2, H2, and V2 represent the atrial, His bundle, and ventricular electrograms in response to S2.
The effective refractory period (ERP) of the atrium is defined as the longest S1-S2 interval at which S2 fails to depolarize the atrium.
The ERP of the A-V node is the longest A1-A2 interval at which A2 depolarizes the atrium but fails to depolarize the His bundle.
The functional refractory period (FRP) of the A-V node is defined as the shortest H1-H2 interval that results from any A1-A2 interval.
The ERP of the His-Purkinje system is defined as the longest H1-H2 interval at which H2 fails to conduct to the ventricles.
The relative refractory period (RRP) of the His-Purkinje system is defined as the longest H1-H2 interval at which H2 conducts to the ventricles with a longer H-V interval than that of the basic drive beat or with a QRS of aberrant configuration.
The ERP of the ventricle is defined as the longest S1-S2 interval at which S2 fails to depolarize the ventricle during ventricular pacing.
RESULTS
The results are summarized in Tables  I and II . Mean values given in these tables were calculated in each group composed of 10dogs.
Sinus cycle length (SCL): Administration of pindolol resulted in prolongation of SCL which occurred within 5min after venous injection of pindolol.
The mean change of the heart rate was a 12% decrease in group 1, an 18% decrease in group 2 and a 19% decrease in group 3, respectively (p<0.001), while there was no significant change in the control group.
Conduction time:
The results of conduction time are summarized in Table I .
Intraatrial conduction time. Pindolol had no effect on the P-A interval during sinus rhythm.
A-V nodal conduction time. Table I summarizes the effects of pindolol on A-V nodal conduction time as measured by A-H interval during sinus rhythm.
The A-H interval was increased by pindolol (mean +5 msec in ARAKAWA, KAMBE, AND SAKAMOTO Jap. Heart J J uly, 1979 group 1, mean +8msec in group 2, mean +10msec in group 3, p<0.001).
The doses of pindolol did not cause second or third degree A-V block. Fig. 1 illustrates the prolongation of the A-H interval in a case of group 3. In the control group, no significant change of the A-H interval was recognized. His-Purkinje conduction time. The H-V interval, which approximates the conduction time through the His-Purkinje system, remained unchanged both in pindolol and control groups.
The QRS interval. Pindolol had no effect on the QRS interval during sinus rhythm. No aberrant ventricular conduction occurred after intravenous Refractory periods:
The results of refractory periods are summarized in Table II. ERP of the atrium. The effective refractory period of the atrium was increased by intravenous pindolol (Fig. 2) ERP of the A-V node. The effective refractory period of the A-V node was prolonged in pindolol groups (Fig. 3) . In group 3, the mean ERP of the A-V node was increased from 138msec to 161msec. In this case, the paced cycle length shows a S1-S1 interval of 285msec. Before administration of pindolol (upper panel), the S1-S2 interval of 145 msec fails to capture the atrium.
In the lower panel, 5min after intravenous administration of 40ug/Kg of pindolol the S1-S2 intreval of 150msec fails to capture the atrium.
Thus, the ERP of the atrium is increased by 5msec after intravenous administration of pindolol.
prolonged from 219 to 231msec in group 1, 215 to 235msec in group 2, 213 to 245msec in group 3, respectively. The control group did not significantly affect the FRP of the A-V node.
ERP and RRP of the His-Purkinje system. Since no block within the His-Purkinje system or prolongation of H-V interval was produced and only a few QRS complexes by extrastimulus showed aberrant configuration in the intact canine heart, the ERP and RRP of the His-Purkinje system were not statistically evaluated.
ERP of the ventricle. Intravenous pindolol prolonged the ERP of the ventricle. Fig. 4 is a case of group 2. Increase rates of the ERP of the ventricle in pindolol groups were about 4% in group 1, 6% in group 2, 6% Fig. 3 . Effects of pindolol on the ERP of the A-V node. This is the same case as Fig. 2 . The basic paced atrial cycle length is 285msec. Before administration of pindolol (upper panel), the ERP of the A-V node amounts to an A, -A2 interval of 150msec. Five min after administration of pindolol (lower panel), block of A above the His bundle occurs at an A, -A2 interval of 165msec. Thus, the ERP of the A-V node is increased by 15msec. Fig. 4 . Effects of pindolol on the ERP of the ventricle in a case of group 2. The basic paced ventricular cycle length is 280msec. Before administration of pindolol (upper panel), the ERP of the ventricle is reached at the longest S1-S2 interval of 165msec at which S2 fails to depolarize the ventricle during ventricular pacing. After administration of pindolol (lower panel), S2 fails to depolarize the ventricle at a S1-S2 interval of 175msec. The ERP of the ventricle, therefore, is increased by 10msec. in group 3, respectively.
Finally, Fig. 5 It may be given orally for antiarrhythmic purposes in doses of 15 to 30mg, or intravenously at a dose of 4 to 12pg/Kg of body weight.
In this study, the intravenous administration of pindolol to anesthetized dogs was performed in a dose range of 4 to 40ug/Kg. The latter dosage of pindolol is above what is considered therapeutically safe in man. Significant effects of intravenous pindolol were observed on sinus cycle length, the A-V nodal conduction time, the ERP of the atrium, the ERP and FRP of the A-V node, and the ERP of the ventricle.
Hill and Turner reported that pindolol with intrinsic sympathomimetic activity, produced less fall in resting heart rate in normal man compared with propranolol.25) In our experiment, sinus cycle length was prolonged, slightly in group 1 but greatly in groups 2 and 3. It seems that beta-blocking action may markedly dominate in overdosis of pindolol. The intraatrial conduction time was not altered by pindolol, while the ERP of the atrium was slightly increased. In prior studies in man, pindolol only slightly prolonged the ERP of the atrium.20) Seides et al reported that the ERP of the atrium was increased by intravenous propranolol in man.5) Josephson et al. described that the ERP of the atrium was increased by a mean of 24msec in 17 out of 21 patients after administration of intramuscular quinidine. 21) In the present study, the A-H interval was generally increased by pindolol without Wenckebach type A-V block, but the H-V interval was unchanged. Therefore, our observations showed that pindolol exerted an influence mostly upon the A-V nodal conduction time in canine hearts, while it showed a lack of the effects on the His-Purkinje conduction time with a large amount of the drug. This feature is similar to those of beta-adrenergic blocking agents such as propranolol etc, in contrast to procaine amide, or quinidine.5),19),22), 26) In most previous reports, it has been shown that the conduction in the His-Purkinje system is insensitive to beta-adrenergic receptor stimulation or blockade.5),27) Thus, unlike procaine amide and quinidine, which depressed the His-Purkinje conduction, pindolol might therefore be indicated in the treatment of arrhythmias which are associated with some degree of intraventricular block. In previous studies, Seides et al reported that propranolol increased the ERP and FRP of the A-V node in man, without consistent effects on the HisPurkinje system, and differed from quinidine and procaine amide in that these drugs decreased the refractory periods of the A-V node and increased the refractory periods of the His-Purkinje system.5) The mechanism of action of beta-blocking agent such as propranolol has been ascribed to both its beta-
